Global Intrauterine Devices (IUD) Market Overview

The global intrauterine devices (IUD) market is projected to grow from an estimated US$ 5.34 billion in 2023 to US$ 7.53 billion by 2032, representing a compound annual growth rate (CAGR) of 3.88% from 2024 to 2032. The expansion of this market is driven by the increasing awareness of effective, long-term contraceptive options, technological advancements in IUDs, and supportive government initiatives for reproductive health and family planning.

Request a free sample copy of the report: https://www.renub.com/intrauterine-devices-market-p.php

Intrauterine Devices: Market Dynamics and Growth Drivers

1. Rising Awareness of Long-Term Contraceptives
   • Increased education on the safety, reliability, and convenience of IUDs is fueling adoption rates globally. IUDs are particularly attractive for women seeking long-term, reversible birth control with minimal maintenance. Initiatives like the U.S. Department of Health and Human Services’ Title X program and coverage mandates under the Affordable Care Act (ACA) have made long-acting reversible contraceptives (LARCs) more accessible, especially among underserved populations. In 2022, the Centers for Disease Control and Prevention (CDC) reported an increase in LARC use among U.S. women aged 15-49, with utilization reaching 11%.
2. Advances in IUD Technology
   • New designs and delivery mechanisms have improved patient comfort and safety, expanding the IUD market to a broader demographic. Recent innovations in hormonal IUDs provide not only contraceptive benefits but also address health conditions like heavy menstruation and dysmenorrhea. Moreover, applications of AI and telemedicine are enhancing service accessibility, especially in remote regions, contributing to market growth.
3. Supportive Healthcare Programs and Policies
   • Government campaigns globally have helped raise awareness about family planning options, particularly the effectiveness and convenience of IUDs over short-term contraceptive methods. Efforts by healthcare providers and non-profit organizations to promote IUD use continue to build trust and acceptance, leading to increased market penetration.

Regional Market Insights

• Europe: Europe sees a robust adoption of IUDs, supported by well-established healthcare systems and growing demand for long-term contraception options. Germany, in particular, has a dynamic IUD market, with strong public health infrastructure promoting the use of both hormonal and copper IUDs.
• Middle East and Africa: Saudi Arabia’s IUD market is expanding, with government-backed programs focusing on women's reproductive health. Similarly, South Africa benefits from public health campaigns promoting IUDs as viable family planning options, often in partnership with non-governmental organizations.

Related Report:

Adhesion Barriers Market

Bariatric Surgery Devices Market

Biopreservation Market

Key Industry Players

Leading companies in the IUD market are actively investing in RD and strategic partnerships to expand access to IUDs globally. Major players include AbbVie Inc., Bayer AG, Teva Pharmaceuticals, ANI Pharmaceuticals, Mylan NV, CooperSurgical Inc., and DKT International.

Recent Company Developments

• January 2024: DKT WomanCare partnered with Medicines360 to expand access to AVIBELA, a high-efficacy hormonal IUD, targeting underserved communities.
• June 2023: Pregna International Limited secured a $16 million investment from India Life Sciences Fund III, aimed at enhancing reproductive health options worldwide.
• August 2022: The FDA approved Bayer AG’s new usage extension for the Mirena IUD, allowing it to be effective for up to eight years.

Market Segmentation

The IUD market can be segmented by type and end-use:

• Type: Hormonal IUDs and Copper IUDs
• End Use: Hospitals, Gynecology Clinics, Community Health Centers, and Others

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4.     Market Dynamics

4.1       Growth Drivers

4.2       Challenges

5. Intrauterine Devices Market

6. Market Share Analysis

6.1       By Type

6.2       By End Use

6.3       By Countries

7. Type

7.1       Hormonal IUD

7.2       Copper IUD

8. End Use

8.1       Hospital

8.2       Gynecology Clinics

8.3       Community Health Care Centers

8.4       Others

9. Countries

9.1       North America 

9.1.1           United States

9.1.2           Canada

9.2       Europe 

9.2.1           France

9.2.2           Germany

9.2.3           Italy

9.2.4           Spain

9.2.5           United Kingdom

9.2.6           Belgium

9.2.7           Netherlands

9.2.8           Turkey

9.3       Asia Pacific 

9.3.1           China

9.3.2           Japan

9.3.3           India

9.3.4           South Korea

9.3.5           Thailand

9.3.6           Malaysia

9.3.7           Indonesia

9.3.8           Australia

9.3.9           New Zealand

9.4       Latin America 

9.4.1           Brazil

9.4.2           Mexico

9.4.3           Argentina

9.5       Middle East Africa 

9.5.1           Saudi Arabia

9.5.2           UAE

9.5.3           South Africa   

10. Porter’s Five Forces Analysis 

10.1   Bargaining Power of Buyers

10.2   Bargaining Power of Suppliers

10.3   Degree of Rivalry

10.4   Threat of New Entrants

10.5   Threat of Substitutes

11. SWOT Analysis

11.1.1        Strength

11.1.2        Weakness

11.1.3        Opportunity

11.1.4        Threat

12. Key Players Analysis 

12.1     AbbVie Inc.

12.1.1        Overview

12.1.2        Key Persons

12.1.3        Recent Development Strategies

12.1.4        Revenue Analysis       

12.2   Bayer AG

12.2.1        Overview

12.2.2        Key Persons

12.2.3        Recent Development Strategies

12.2.4        Revenue Analysis

12.3   Teva Pharmaceuticals

12.3.1        Overview

12.3.2        Key Persons

12.3.3        Recent Development Strategies

12.3.4        Revenue Analysis

12.4   ANI Pharmaceuticals

12.4.1        Overview

12.4.2        Key Persons

12.4.3        Recent Development Strategies

12.4.4        Revenue Analysis

12.5   Mylan NV

12.5.1        Overview

12.5.2        Key Persons 

12.5.3        Recent Development Strategies

12.5.4        Revenue Analysis

12.6   CooperSurgical Inc.

12.6.1         Overview

12.6.2        Key Persons

12.6.3        Recent Development Strategies

12.6.4        Revenue Analysis

12.7   DKT International

12.7.1        Overview

12.7.2        Key Persons

12.7.3        Recent Development Strategies

12.8   Melbea AG

12.8.1        Overview

12.8.2        Key Persons

12.8.3        Recent Development Strategies

1. Introduction

2. Research Methodology

3. Executive Summary

4.     Market Dynamics

4.1       Growth Drivers

4.2       Challenges

5. Intrauterine Devices Market

6. Market Share Analysis

6.1       By Type

6.2       By End Use

6.3       By Countries

7. Type

7.1       Hormonal IUD

7.2       Copper IUD

8. End Use

8.1       Hospital

8.2       Gynecology Clinics

8.3       Community Health Care Centers

8.4       Others

9. Countries

9.1       North America 

9.1.1           United States

9.1.2           Canada

9.2       Europe 

9.2.1           France

9.2.2           Germany

9.2.3           Italy

9.2.4           Spain

9.2.5           United Kingdom

9.2.6           Belgium

9.2.7           Netherlands

9.2.8           Turkey

9.3       Asia Pacific 

9.3.1           China

9.3.2           Japan

9.3.3           India

9.3.4           South Korea

9.3.5           Thailand

9.3.6           Malaysia

9.3.7           Indonesia

9.3.8           Australia

9.3.9           New Zealand

9.4       Latin America 

9.4.1           Brazil

9.4.2           Mexico

9.4.3           Argentina

9.5       Middle East Africa 

9.5.1           Saudi Arabia

9.5.2           UAE

9.5.3           South Africa   

10. Porter’s Five Forces Analysis 

10.1   Bargaining Power of Buyers

10.2   Bargaining Power of Suppliers

10.3   Degree of Rivalry

10.4   Threat of New Entrants

10.5   Threat of Substitutes

11. SWOT Analysis

11.1.1        Strength

11.1.2        Weakness

11.1.3        Opportunity

11.1.4        Threat

12. Key Players Analysis 

12.1     AbbVie Inc.

12.1.1        Overview

12.1.2        Key Persons

12.1.3        Recent Development Strategies

12.1.4        Revenue Analysis       

12.2   Bayer AG

12.2.1        Overview

12.2.2        Key Persons

12.2.3        Recent Development Strategies

12.2.4        Revenue Analysis

12.3   Teva Pharmaceuticals

12.3.1        Overview

12.3.2        Key Persons

12.3.3        Recent Development Strategies

12.3.4        Revenue Analysis

12.4   ANI Pharmaceuticals

12.4.1        Overview

12.4.2        Key Persons

12.4.3        Recent Development Strategies

12.4.4        Revenue Analysis

12.5   Mylan NV

12.5.1        Overview

12.5.2        Key Persons 

12.5.3        Recent Development Strategies

12.5.4        Revenue Analysis

12.6   CooperSurgical Inc.

12.6.1         Overview

12.6.2        Key Persons

12.6.3        Recent Development Strategies

12.6.4        Revenue Analysis

12.7   DKT International

12.7.1        Overview

12.7.2        Key Persons

12.7.3        Recent Development Strategies

12.8   Melbea AG

12.8.1        Overview

12.8.2        Key Persons

12.8.3        Recent Development Strategies

About the Company: 

Renub Research is a Market Research and Information Analysis company with more than 15 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers acquisitions, etc. Till now we have published more than 9000 syndicated reports and worked on more than 750 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.

Media Contact:

Company Name: Renub Research

Contact Person: Rajat Gupta, Marketing Manager

Phone No: +91-120-421-9822 (IND) | +1-478-202-3244 (USA)

Email: info@renub.com